Azerbaijani
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency

Yalnız qeydiyyatdan keçmiş istifadəçilər məqalələri tərcümə edə bilərlər
Giriş / Qeydiyyatdan keçin
Bağlantı panoya saxlanılır
StatusHələ işə qəbul edilmir
Sponsorlar
Orlando Health, Inc.
Əməkdaşlar
ChiRhoClin, Inc.

Açar sözlər

Mücərrəd

This is a 3-year prospective study too identify the role of exocrine pancreatic insufficiency in patients with abdominal pain who are undergoing upper endoscopy. An endoscopic pancreatic function test (ePFT) with secretin will be performed in children undergoing routine investigative EGD.
The goal of this study is to identify the role of exocrine pancreatic insufficiency in patients with abdominal pain who are undergoing upper endoscopy, who otherwise would be labelled as recurrent abdominal pain (RAP).

Təsvir

Recurrent abdominal pain (RAP) is an often encountered complaint in children and adolescents. The evaluation of the child or adolescent with recurrent abdominal pain requires an understanding of the pathogenesis of abdominal pain, the most common causes of abdominal pain, and the typical patterns of presentation.

Children and adolescents frequently undergo esophagogastroduodenoscopy (EGD) to evaluate complaint and recurrent abdominal pain is a frequently cited reason for endoscopy. This is a standard procedure where an endoscope is passed through the mouth, esophagus, stomach and into the first part of the small intestine. With the camera at the end of the endoscope, the endoscopist is able to see the gross appearance of the upper digestive tract. Small biopsy samples are collected from the small intestine, stomach and esophagus to evaluate for mucosal injury, irritation, infection or other anomalies that could be contributing to the patient's symptoms. This is helpful for evaluation of histological changes, but does not provide information about its function.

Pancreatic stimulation testing with secretagogue (secretin, cholecystokinin) administration, and direct pancreatic fluid collection is considered a gold standard to assess the exocrine pancreatic function. Indirect testing of pancreatic function such as with urine or stool has much lower sensitivity and specificity compared to direct pancreatic fluid collection.

This is a prospective study where patients undergoing investigative EGD will have endoscopic pancreatic function test (ePFT) with secretin.

There will be two groups:

The first group are patients that are undergoing EGD with ePFT for evaluation of suspected or established pancreatic insufficiency with symptoms such as failure to thrive or malabsorption. These patients are the ones that historically have had ePFT testing done to evaluate their pancreatic function.

The second group is all patients that are undergoing scheduled diagnostic EGD for other reasons that consent for pancreatic stimulation testing. These patients are usually undergoing EGD for a range of symptoms that frequently include recurrent abdominal pain, bloating, diarrhea, nausea and/or constipation. These patients do not typically have ePFT testing performed and is not usually thought to be part of the standard of care for this group.

Tarixlər

Son Doğrulandı: 12/31/2019
İlk təqdim: 01/08/2020
Təxmini qeydiyyat təqdim edildi: 01/12/2020
İlk Göndərmə: 01/17/2020
Son Yeniləmə Göndərildi: 01/12/2020
Son Yeniləmə Göndərildi: 01/17/2020
Həqiqi Təhsilin Başlama Tarixi: 12/31/2019
Təxmini İlkin Tamamlanma Tarixi: 11/30/2023
Təxmini İşin Tamamlanma Tarixi: 11/30/2023

Vəziyyət və ya xəstəlik

Abdominal Pain
Irritable Bowel Syndrome

Müdaxilə / müalicə

Drug: synthetic human secretin

Faza

Faza 3

Qol Qrupları

QolMüdaxilə / müalicə
Active Comparator: ChiRhoStim Group 1
Patients undergoing EGD with ePFT for symptoms of suspected or known pancreatic insufficiency.
Experimental: ChiRhoStim Group 2
Patients undergoing diagnostic EGD that consent to undergo ePFT.

Uyğunluq Kriteriyaları

Təhsil üçün uyğun yaşlar 6 Months Üçün 6 Months
Təhsilə Uyğun CinslərAll
Sağlam Könüllüləri qəbul edirBəli
Kriteriyalar

Inclusion Criteria:

- For Group 1- Patients undergoing EGD with ePFT for symptoms of suspected or known pancreatic insufficiency

- For Group 2- Patients undergoing diagnostic EGD who consent to undergo ePFT

Exclusion Criteria:

- If it is an emergency EGD procedure

- If the caregiver refuses to sign the consent form

- Patient has undergone ePFT testing previously with a documented allergy to human secretin

- Patients that require atropine at the time of sedation

Nəticə

İlkin nəticə tədbirləri

1. Prevalence of pancreatic insufficiency in Pediatric cases undergoing upper endoscopy for Abdominal Pain [2.5 years]

Secretin stimulated exocrine pancreatic enzyme activity will be measured in patients with abdominal pain who are undergoing upper endoscopy to identify those with insufficiency (EPI).

İkincili Nəticə Tədbirləri

1. Secondary biomarkers for exocrine pancreatic insufficiency in blood and pancreatic fluid will be measured to explore mechanisms involved leading to abdominal pain and become potential tests in future. [2.5 years]

This includes immunological and genetic markers.

Facebook səhifəmizə qoşulun

Elm tərəfindən dəstəklənən ən tam dərman bitkiləri bazası

  • 55 dildə işləyir
  • Elm tərəfindən dəstəklənən bitki mənşəli müalicələr
  • Təsvirə görə otların tanınması
  • İnteraktiv GPS xəritəsi - yerdəki otları etiketləyin (tezliklə)
  • Axtarışınızla əlaqəli elmi nəşrləri oxuyun
  • Təsirlərinə görə dərman bitkilərini axtarın
  • Maraqlarınızı təşkil edin və xəbər araşdırmaları, klinik sınaqlar və patentlər barədə məlumatlı olun

Bir simptom və ya bir xəstəlik yazın və kömək edə biləcək otlar haqqında oxuyun, bir ot yazın və istifadə olunan xəstəliklərə və simptomlara baxın.
* Bütün məlumatlar dərc olunmuş elmi araşdırmalara əsaslanır

Google Play badgeApp Store badge